Absci (ABSI) Stock Price, News & Analysis

Company Overview

Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to create biologics for patients. Its integrated drug creation platform is designed to improve upon traditional biologic drug discovery by using AI to simultaneously optimize multiple drug characteristics that may be important to development and therapeutic benefit. The company was founded in 2011 and is headquartered in Vancouver, Washington.

Key Stats

• Today's Range: $3.65 to $4.38
• 50-Day Range: $2.62 to $4.38
• 52-Week Range: $2.45 to $6.72
• Volume: 12.38 million shs
• Average Volume: 7.59 million shs
• Market Capitalization: $499.62 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $8.57
• Consensus Rating: Buy

Absci Stock Analysis - MarketRank™

Absci scored higher than 40% of companies evaluated by MarketBeat, and ranked 727th out of 955 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Buy

Consensus Rating

Absci has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 7 buy ratings, no hold ratings, and no sell ratings.

Amount of Analyst Coverage

Absci has only been the subject of 4 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Absci are expected to grow in the coming year, from ($0.89) to ($0.69) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Absci is -4.68, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Absci is -4.68, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Absci has a P/B Ratio of 2.29. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

23.02% of the float of Absci has been sold short.

Short Interest Ratio / Days to Cover

Absci has a short interest ratio ("days to cover") of 6.

Change versus previous month

Short interest in Absci has recently increased by 37.12%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Absci does not currently pay a dividend.

Dividend Growth

Absci does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

23.02% of the float of Absci has been sold short.

Short Interest Ratio / Days to Cover

Absci has a short interest ratio ("days to cover") of 6.

Change versus previous month

Short interest in Absci has recently increased by 37.12%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 2.4 / 5
• News Sentiment: 0.24

News Sentiment

Absci has a news sentiment score of 0.24. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.44 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 3 news articles for Absci this week, compared to 3 articles on an average week.

Search Interest

12 people have searched for ABSI on MarketBeat in the last 30 days. This is an increase of 50% compared to the previous 30 days.

MarketBeat Follows

19 people have added Absci to their MarketBeat watchlist in the last 30 days. This is an increase of 111% compared to the previous 30 days.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Absci insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 9.81% of the stock of Absci is held by insiders.

Percentage Held by Institutions

52.05% of the stock of Absci is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

ABSI Stock Analysis - Frequently Asked Questions

How have ABSI shares performed this year?

Absci's stock was trading at $2.62 on January 1st, 2025. Since then, ABSI shares have increased by 66.0% and is now trading at $4.35.
View the best growth stocks for 2025 here.

How were Absci's earnings last quarter?

Absci Co. (NASDAQ:ABSI) issued its earnings results on Tuesday, November, 12th. The company reported ($0.24) earnings per share for the quarter, missing analysts' consensus estimates of ($0.19) by $0.05. The business earned $1.70 million during the quarter, compared to the consensus estimate of $1.77 million. Absci had a negative trailing twelve-month return on equity of 46.56% and a negative net margin of 2,321.56%.

When did Absci IPO?

Absci (ABSI) raised $200 million in an initial public offering on Thursday, July 22nd 2021. The company issued 12,500,000 shares at a price of $15.00-$17.00 per share.

Who are Absci's major shareholders?

Top institutional investors of Absci include ARK Investment Management LLC (7.20%), Sumitomo Mitsui Trust Group Inc. (1.00%), Institute for Wealth Management LLC. (0.41%) and Rhumbline Advisers (0.10%). Insiders that own company stock include Phoenix Venture Partners Ii Lp, Redmile Group, Llc, Zachariah Jonasson and Sarah Korman.
View institutional ownership trends.

How do I buy shares of Absci?

Shares of ABSI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Absci own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Absci investors own include Invesco QQQ (QQQ), NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), Advanced Micro Devices (AMD), Arista Networks (ANET) and CrowdStrike (CRWD).

Company Calendar

• Last Earnings: 11/12/2024
• Today: 2/05/2025
• Next Earnings (Estimated): 3/20/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Commercial physical research
• Sub-Industry: Business Services
• Current Symbol: NASDAQ:ABSI
• CUSIP: N/A
• CIK: 1672688
• Web: www.absci.com
• Phone: 360-949-1041
• Fax: N/A
• Employees: 210
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $8.57
• High Stock Price Target: $13.00
• Low Stock Price Target: $5.00
• Potential Upside/Downside: +97.0%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 7 Analysts

Profitability

• EPS (Most Recent Fiscal Year): ($0.93)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-110,570,000.00
• Net Margins: -2,321.56%
• Pretax Margin: -2,319.25%
• Return on Equity: -46.56%
• Return on Assets: -39.74%

Debt

• Debt-to-Equity Ratio: 0.01
• Current Ratio: 5.63
• Quick Ratio: 5.63

Sales & Book Value

• Annual Sales: $4.21 million
• Price / Sales: 118.76
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $1.90 per share
• Price / Book: 2.29

Miscellaneous

• Outstanding Shares: 114,856,000
• Free Float: 103,589,000
• Market Cap: $499.62 million
• Optionable: Optionable
• Beta: 2.11